AU1208599A - Glycosylated obesity protein analogs - Google Patents

Glycosylated obesity protein analogs

Info

Publication number
AU1208599A
AU1208599A AU12085/99A AU1208599A AU1208599A AU 1208599 A AU1208599 A AU 1208599A AU 12085/99 A AU12085/99 A AU 12085/99A AU 1208599 A AU1208599 A AU 1208599A AU 1208599 A AU1208599 A AU 1208599A
Authority
AU
Australia
Prior art keywords
glycosylated
protein analogs
obesity protein
obesity
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12085/99A
Inventor
John Michael Beals
John Edward Hale
Steven Duane Hatch
Joseph Vincent Junior Rinella
Brigitte Elisabeth Schoner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1208599A publication Critical patent/AU1208599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU12085/99A 1997-10-31 1998-11-02 Glycosylated obesity protein analogs Abandoned AU1208599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6414197P 1997-10-31 1997-10-31
US60064141 1997-10-31
PCT/US1998/023323 WO1999023115A1 (en) 1997-10-31 1998-11-02 Glycosylated obesity protein analogs

Publications (1)

Publication Number Publication Date
AU1208599A true AU1208599A (en) 1999-05-24

Family

ID=22053836

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12085/99A Abandoned AU1208599A (en) 1997-10-31 1998-11-02 Glycosylated obesity protein analogs

Country Status (2)

Country Link
AU (1) AU1208599A (en)
WO (1) WO1999023115A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781460B2 (en) * 1999-02-12 2005-05-26 Amgen, Inc. Glycosylated leptin compositions and related methods

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008087121A1 (en) * 2007-01-17 2008-07-24 Merz Pharma Gmbh & Co. Kgaa Use of a surfactant for the preparation of a formulation for the treatment of adipose dieseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153310A (en) * 1989-02-28 1992-10-06 Du Pont Merck Pharmaceutical Company Il-2 analogs containing n-linked glycosylation sites
JPH05178899A (en) * 1990-07-31 1993-07-20 Toray Ind Inc Modified polypeptide and therapeutic agent for thrombocytosis containing the same as active ingredient
ATE246000T1 (en) * 1992-06-03 2003-08-15 Genentech Inc VARIANTS OF TISSUE PLASMINOGEN ACTIVATOR WITH IMPROVED THERAPEUTIC EFFECTS
AU4766196A (en) * 1995-01-31 1996-08-21 Eli Lilly And Company Anti-obesity proteins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781460B2 (en) * 1999-02-12 2005-05-26 Amgen, Inc. Glycosylated leptin compositions and related methods

Also Published As

Publication number Publication date
WO1999023115A1 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
HU9601120D0 (en) Recombinant obese proteins
AU6868398A (en) Mu-opiate receptor peptides
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
EP1018551A4 (en) Megsin protein
ZA963530B (en) Recombinant obese (ob) proteins
AU1750997A (en) Obesity protein formulations
AU1705197A (en) Obesity protein formulations
AU1999999A (en) Contryphan peptides
AU2243997A (en) Obesity protein formulations
AU6000698A (en) Proteins
AU1747297A (en) Obesity protein formulations
AU6275098A (en) Novel h-rev 107-like protein
AU1208599A (en) Glycosylated obesity protein analogs
GB9720784D0 (en) Protein
AU6569998A (en) Obesity protein formulations
AU9318798A (en) Ras-like protein
IL120979A0 (en) Glycosylated TNF
AU6771698A (en) Process for preparing obesity protein analogs
AU7269298A (en) New ras-like protein
AU6040598A (en) Blnk proteins
AU1506599A (en) Novel protein
AU5919998A (en) Obesity protein formulations
AU8231998A (en) Glycosylation peptides
EP0971742A4 (en) Obesity protein formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase